This activity will cover HAE genetics and diagnostics with a focus on HAE-nl-C1INH, emerging therapies, and patient-centered care.
Upon completion of this activity, participants should be better able to:
President/CEO
US HAEA
Fairfax City, VA
Professor, Medicine, UCSD Department of Medicine
Director, US HAE Angioedema Center at UCSD University of California School of Medicine
La Jolla, CA
Research Scientist, Veterans Medical Research Foundation
VA Staff Physician and Chief, Section of Allergy San Diego
Veterans Affairs Medical Center
San Diego, CA
Associate Professor, Medicine
Harvard Medical School
Program and Assistant Clinical Director
Allergy and Immunology Training Program Division of Rheumatology, Allergy and Immunology
Massachusetts General Hospital
Boston, MA
Clinical Professor, Internal Medicine
University of Texas Southwestern Medical School
Dallas, TX
Professor, Medicine
Clinical Director, US HAEA Angioedema Center
Clinical Service Chief, Allergy & Immunology
Division of Rheumatology, Allergy & Immunology
University of California, San Diego
San Diego, CA
RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy.
Anthony J. Castaldo, has no relevant financial relationship(s) with ineligible companies to disclose.
Aleena Banerji, MD, has relevant financial relationships with BioCryst Pharmaceuticals, Ionis Pharmaceuticals, Inc., KalVista Pharma, Pharvaris, Takeda (Consultant); BioCryst Pharmaceuticals, Ionis Pharmaceuticals, Inc., KalVista Pharma, Takeda (Researcher).
William R. Lumry, MD, has relevant financial relationships with Astria, BioCryst Pharmaceuticals, BioMarin Pharmaceuticals Inc., CSL Behring, Express Scripts/CVS, Fresenius Kabi, Intellia Therapeutics, Inc., KalVista Pharma, Magellan, Optum, Pharming Group N.V., Pharvaris, Shire, Takeda (Consultant); CSL Behring, Grifols S.A., Ionis Pharmaceuticals, Inc., KalVista Pharma, Shire/Takeda, Teva Pharmaceuticals USA (Grant/Research Support); AstraZeneca, BioCryst Pharmaceuticals, CSL Behring, Grifols S.A., GSK, OptiNose, Inc, Pharming Group N.V., Shire/Takeda, Sanofi/Regeneron (Speakers’ Bureau).
Marc A. Riedl, MD, MS, has relevant financial relationships with Astria, BioCryst Pharmaceuticals, BioMarin Pharmaceuticals Inc., CSL Behring, Cycle Pharmaceuticals Ltd, Grifols S.A., Intellia Therapeutics, Inc., Ipsen, KalVista Pharma, Ono Pharmaceutical Co., Ltd, Pfizer, Pharming Group N.V., Pharvaris, REGENXBIO Inc., Sanofi/Regeneron, Spark, Takeda (Consultant); BioCryst Pharmaceuticals, BioMarin Pharmaceuticals Inc., CSL Behring, Ionis Pharmaceuticals, Inc., KalVista Pharma, Pharvaris, Takeda (Grant/Research Support); Grifols S.A., Pharming Group N.V., Takeda (Speaker/Speakers’ Bureau).
Bruce L. Zuraw, MD, has relevant financial relationships with BioCryst Pharmaceuticals, CSL Behring, Takeda (Consultant); Ionis Pharmaceuticals, Inc. (Independent Contractor, including Contracted Research); BioMarin Pharmaceuticals Inc., Genentech, Novartis (Other, Data Safety Monitoring).
All of the relevant financial relationships listed for these individuals have been mitigated according to RMEI policies.
In support of improving patient care, this activity has been planned and implemented by RMEI Medical Education, LLC and the US Hereditary Angioedema Association (HAEA). RMEI Medical Education, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
RMEI Medical Education, LLC designates this enduring material for a maximum of 1.0 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education
RMEI Medical Education, LLC designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number – JA4008290-9999-23-003-H01-P)
Type of Activity: Knowledge
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour(s).
In order to receive credit, participants must review the activity content and complete the evaluation. If you have questions about this activity, please contact RMEI at [email protected].
Users must:
There is no fee to participate.
Your Feedback is Important!
COMPLETE THE EVALUATION FORM AND YOU WILL BE ENTERED INTO A DRAWING
FOR A $100* AMAZON GIFT CARD!
*The expense for this gift card is solely funded by RMEI Medical Education, LLC.
No supporter funding was used for the expense of this gift card.
Rules and Regulations
This sweepstakes is managed by RMEI Medical Education, LLC (RMEI), a jointly accredited provider. The winner will be selected via automated random drawing on a quarterly basis from among all eligible entries and notified through the contact information provided. In accordance with our privacy policy, we do not share your information with any third parties. By entering the sweepstakes, you grant RMEI permission to use your e-mail address to reach you for notification and prize fulfillment. Only individuals who complete the evaluation forms and provide contact information will be eligible to win. Open to those who have a US postal address and who are 18 years or older. Only one prize per person and per household will be awarded. The prize will be a $100 Amazon gift card.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources